Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 8Terminated 3Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 2Radiation Injuries 1Neurotoxicity Syndromes 1Glioma 1Central Nervous System Neoplasms 1Carcinoma, Medullary 1

Interventions

Cyclophosphamide 390Carboplatin 343Gemcitabine 331pembrolizumab 330Cisplatin 327Paclitaxel 295Radiotherapy 292Docetaxel 286Bevacizumab 249Rituximab 233Capecitabine 222Nivolumab 220Dexamethasone 205Fluorouracil 189fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 134fludarabine phosphate 129Bortezomib 129Cetuximab 127Lenalidomide 125Filgrastim 120Erlotinib Hydrochloride 119Temozolomide 111Ipilimumab 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Interventional × Lithium Carbonate × Clear all
NCT00582712 2019-12-09

An Initial Study of Lithium in Patients With Medullary Thyroid Cancer

University of Wisconsin, Madison

Phase 2 Terminated
5 enrolled 7 charts

Carcinoma, Medullary

NCT01105702 2016-08-04

Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma

NYU Langone Health

Phase 2 Terminated
28 enrolled 9 charts
CNS

Brain Neoplasms, Glioma

NCT00469937 2012-02-28

Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases

Vanderbilt-Ingram Cancer Center

Phase 1 Terminated
9 enrolled
CNS

Brain Neoplasms, Radiation Injuries, Central Nervous System Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡